Swampscott, MA, United States of America

Samuel D Rabkin

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Georgetown University, The General Hospital Corporation, Catherex, Inc.. Active years: 1996-2020.

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 2

Average Co-Inventor Count = 3.4

ph-index = 10

Forward Citations = 227(Granted Patents)

Location History:

Bethesda, MD (US) (1996 - 2012)
Lynn, MA (US) (2006 - 2013)
Chevy Chase, MD (US) (2002 - 2017)
Swampscott, MA (US) (2012 - 2020)

Company Filing History:

14 out of 496

Georgetown University

patents

7 out of 3,068

The General Hospital Corporation

where one patent can have more than one assignee

Years Active: 1996-2020

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10532095 - Viral vectors and their use in therapeutic methods (2020-01-14),

2. 9827307 - Use of herpes vectors for tumor therapy (2017-11-28),

3. 9555072 - Viral vectors and their use in therapeutic methods (2017-01-31),

4. 8871193 - Viral vectors and their use in therapeutic methods (2014-10-28),

5. 8703120 - Use of oncolytic herpes viruses for killing cancer stem cells (2014-04-22),

6. 8470577 - Viral vectors and their use in therapeutic methods (2013-06-25),

7. 8361978 - Use of herpes vectors for tumor therapy (2013-01-29),

8. 8313896 - Oncolytic herpes simplex virus immunotherapy in the treatment of brain cancer (2012-11-20),

9. 8273568 - Replication-competent herpes simplex virus mediates destruction of neoplastic cells (2012-09-25),

10. 7749745 - Viral vectors and their use in therapeutic methods (2010-07-06),

11. 7064111 - Use of soluble costimulatory factor for tumor immuno-gene therapy (2006-06-20),

12. 6699468 - Replication-competent herpes simplex virus mediates destruction of neoplastic cells (2004-03-02),

13. 6379674 - Use of herpes vectors for tumor therapy (2002-04-30),

14. 6139834 - Replication-competent Herpes simplex virus mediates destruction of (2000-10-31),

15. 5728379 - Tumor- or cell-specific herpes simplex virus replication (1998-03-17),

Title: The Innovative Journey of Samuel D. Rabkin

Introduction: Samuel D. Rabkin, a pioneering inventor hailing from Swampscott, MA (US), has made significant contributions to the field of innovations with his groundbreaking ideas and inventions.

Latest Patents: Samuel D. Rabkin holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Samuel D. Rabkin has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries such as technology, healthcare, and sustainability. His dedication to creating impactful solutions has earned him recognition as a visionary inventor.

Collaborations: Samuel D. Rabkin has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: In conclusion, Samuel D. Rabkin's passion for innovation, coupled with his relentless pursuit of excellence, has established him as a prominent figure in the world of inventions. His contributions have not only transformed industries but have also inspired future generations of inventors to think outside the box and create a better tomorrow.